RxDoctor Payments Data

Joshua Evans

Gastroenterology · Omaha, NENPI 1861579450

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $29,000 of the $33,720 with a category attached, or 86.0%. AbbVie accounts for 88.8% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2020 at $11,980 and has fallen 99.5% since, to $61 in 2023. Among gastroenterology clinicians in NE with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$33,720in general payments, 2019–2025

Across 207 payments — averaging $162.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$30K
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$2K
  • Takeda Pharmaceuticals U.S.A., Inc.$435
  • QOL Medical, LLC$313
  • Bristol Myers Squibb$280
  • Johnson & Johnson$184
  • plus $279 from 9 others

What the payments were for

  • Consulting fees$180%
  • Speaking & faculty fees$29,00086%
  • Travel & lodging$1,2944%
  • Food & beverage$3,37810%
  • Other$300%

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$33,720 in reported general payments places this provider in the 95th percentile of 89 gastroenterology providers in Nebraska.

See all gastroenterology providers in Nebraska

Other gastroenterology in Omaha

See the full list for Nebraska

Where these figures come from

Is this you, or does something look wrong? →